First Graphene expands globally as graphene sales move toward scale

Funding requirement shadows global expansion

First Graphene Limited (ASX:FGR) has described FY2026 as the year it became a broader international advanced materials business. The audited accounts offer a less comfortable counterpoint: the company recorded a A$5.396 million loss, used A$2.394 million in operating cash and says its ability to continue depends on raising more equity.

The going concern note identifies a “material uncertainty” that could cast significant doubt on the group’s ability to continue as a going concern. The accounts were nevertheless prepared on that basis because management expects further equity placements, while stating that operations would be wound back to a sustainable level if additional funding could not be obtained.

Revenue improves while losses remain substantial

Revenue from customer contracts increased to A$537,594 from A$468,397, an uplift of about 15%. Gross profit more than doubled to A$220,562 as cost of goods sold fell to A$317,032, while research and development expenditure declined to A$947,911 from A$1.336 million.

Those gains did not yet translate into profitability. General and administrative costs remained the largest operating expense at A$2.863 million, and finance expense rose to A$1.749 million. The annual loss narrowed only modestly from A$5.492 million, leaving the balance sheet reliant on capital markets despite year-end cash of A$2.866 million.

Acquisitions broaden product and market access

First Graphene spent A$350,649 on asset acquisitions during the year. The MITO Material Solutions assets added functionalised graphene oxide and nanomaterial products, a US customer base and formulations used in sporting equipment, while the Ionic Industries and Imagine Intelligent Materials assets brought coating, dispersion and geotextile-related technology.

Management says the expanded portfolio now spans graphene, graphene oxide, carbon additives, dry powders, dispersions, aqueous pastes and resin-compatible masterbatches. The report also identifies more than 35 active commercial clients, 11 distribution partners across more than 20 countries and a near-term PureGRAPH pipeline of more than 50 launches and commercial agreements. Those pipeline figures are described by the company as representing more than US$10 million of near-term revenue opportunity, not booked revenue.

Cement and US commercialisation set the test

The company’s most ambitious growth initiatives centre on China and the United States. First Graphene signed a memorandum of understanding appointing The Sixth Element as a key distributor for PureGRAPH CEM in China, with the chairman saying the relationship could lead to higher production volumes and a Chinese manufacturing arrangement. The report says further progress was expected by the end of 2026.

In the US, the MITO acquisition provides a direct operating presence and a pipeline of more than 25 clients in late-stage testing across defence, aerospace, transport and composites, according to management. First Graphene also points to UK cement deployments exceeding 20,000 tonnes and a first production order from Pacific Urethanes for mining-related applications as evidence of commercial traction.

Technical validation still needs to become recurring sales

The research portfolio contains credible-looking application results, but the financial report makes clear that commercial conversion remains the task ahead. PureGRAPH-enhanced waterproofing material tested with Glade Chemicals reduced secondary water absorption by more than 17% at 28 days and 48% at 400 days, after which the product launched commercially and received recurring orders from Revelstone.

The A$3.72 million HyPStore project reached final integration of a composite liquid-hydrogen tank, with PureGRAPH-reinforced epoxy showing an 18% increase in strength and a 47% increase in modulus against neat resin under cryogenic testing. These results support the technology case, but they do not remove the immediate requirement to fund operations while the company pursues recurring revenue.

Equity funding and dilution remain live issues

First Graphene finished FY2026 with 883.9 million shares on issue, compared with 748.8 million a year earlier. It also had 123.1 million options and 12.5 million performance rights outstanding at year-end, with a further 3.0 million performance rights converted into shares during August and September 2026.

The next chapter therefore has two tests running in parallel: whether the US, Chinese cement and mining opportunities produce material recurring sales, and whether the company can finance that conversion without placing further pressure on existing shareholders. Until those questions are answered, the promise of scale remains closely tied to the terms and timing of the next capital raise.